Seema leads BioIVT’s analytical services team where she works with a wide range of drug candidates in many different molecular classes. Discover how Seema and her team deliver high-quality bioanalytical support: https://t.co/25wW8yDYn3 #ItsPersonal #Bioanalysis

For many of the scientists on our team, their work is #personal. Their own lives & families are directly impacted by the diseases they seek to combat through research. Etsuko Usuki, Director of #ADME research services in KC, is no exception: https://t.co/gty4hI6iOp #ItsPersonal

Meet Brad Evans, PhD a translational scientist with 20+ years of experience turning cutting-edge research into real-world impact. Learn more about what drives Dr. Evans’ scientific curiosity and work at BioIVT: https://t.co/XgqA82og6Z

What challenges need to be addressed for #LiquidBiopsy Research to be able to reach its full potential? Watch our webinar to explore: ➡️ Biobanking Issues ➡️ Understanding & Controlling Variables ➡️ Importance of Diversity Access the full webinar: https://t.co/Kbx4BrRNtd

Our cell- & enzyme-based screening assays determine the total #antioxidant capacity of biological fluids, cells, tissue & naturally occurring or synthetic compounds that may be used as ingredients in dietary supplements, topical protection & therapeutics: https://t.co/uc2MTiHhuA

Dr. Grindstaff, Consulting Director at BioIVT, anticipates continued growth in regulatory acceptance of #NewApproachMethodologies (#NAMs) as we move into 2026. Learn more about NAMs and why you should consider them for your research: https://t.co/r8frJ3jTRI

This week! Join us to learn about strategies for generating TCR-T and endogenous antigen-specific #Tcells including comparisons with CAR-T and other modalities and how to address key hurdles in specificity, durability, and exhaustion: https://t.co/f5YrUyAf1O

Behind every breakthrough is a team of researchers & donors who gave them the biospecimens needed to make it happen. We’re proud to play a role in that process—if you’re curious about how you can help, start here: US: https://t.co/W9hqaGI22M UK: https://t.co/96ylNxqFsR

Join us Jan. 30 to hear a panel of experts from FDA, industry and NAM development discuss the barriers, breakthroughs and road to adoption for #NewApproachMethodologies (#NAMs), including audience Q&A. Don’t miss this extraordinary event: https://t.co/5UY7v5fzCb

We’ve been awarded @scientist_com’s Supplier Recognition Award for “outstanding performance in offering drug discovery research services” based on our response times, customer satisfaction ratings, etc. Access our products & services on Scientist .com: https://t.co/w5H6VVF1MH

Choosing the right cellular starting & raw materials vendor for your #CellandGeneTherapy program is crucial. Discover 3 key strategies to evaluate & find the perfect fit. ➡️ https://t.co/kpoVLGDonf #CellTherapy #GeneTherapy #AdvancedTherapies #QualityControl #VendorSelection

Ochratoxin A (OTA) is a common foodborne toxin linked to chronic kidney disease. It’s extremely stable & has a reported half-life of 35 days in humans. In a new collaborative publication, we show a mechanism by which OTA can accumulate in the kidney: https://t.co/5kuoA5RtuE

Choosing the right cellular starting & raw materials vendor for your #CellandGeneTherapy program is crucial. Discover 3 key strategies to evaluate & find the perfect fit. ➡️ https://t.co/URhRQUGBnc #CellTherapy #GeneTherapy #AdvancedTherapies #QualityControl #VendorSelection

Pathology is the cornerstone of disease diagnosis & treatment planning bringing life-saving insights to patients faster. Integrating #AI into validated #DigitalPathology workflows can dramatically improve speed & access to accurate #diagnostics. Learn more- https://t.co/Q05fFfR23f

📬 Our Dec. New Scientific Resources #Newsletter is now available: https://t.co/OKlOy0oHac Want to stay informed about BioIVT’s new scientific posters, presentations, and publications? Subscribe now! LinkedIn: https://t.co/WNDTHYqDhz Email:

#Exosomes are nano-sized extracellular vesicles (EVs) that carry biological information from one cell to another. Due to their unique role and properties, they offer substantial opportunities. Learn more: https://t.co/HpS4QLmk55

The best time to prepare is before you need it. Use your remaining 2025 budget to secure the biospecimens and studies you’ll need in 2026…before the storm rolls in. BioIVT has you covered: https://t.co/s5nJMXzIXP

For Becky Campbell, Principal Scientist at our Kansas City site, her “why” has grown and deepened over more than 20 years at XenoTech/BioIVT. #ItsPersonal #WhyWeDoWhatWeDo

Diversity in donor profiles is essential for understanding metabolic health, enabling more accurate, translatable findings. Explore critical considerations: https://t.co/lQ6tMe7Sf6 and dive into FDA guidance & the case for using waist circumference: https://t.co/8Sywtm3Ww1

Did you know direct ordering is available on our website for ready-to-ship, standard-size aliquots of a wide range of our #biospecimens? Get competitive pricing, shorter lead times & the ease of online ordering: https://t.co/P8fMiPdhAL